PATENT CLAIM ANALYSIS

Application Number: 15870000
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["435", "252100"]

Abstract:
A composition comprising intact minicells that contain a drug molecule is useful for targeted drug delivery. One targeted drug delivery method employs bispecific ligands, comprising a first arm that carries specificity for a bacterially derived minicell surface structure and a second arm that carries specificity for a mammalian cell surface receptor, to target drug-loaded minicells to specific mammalian cells and to cause endocytosis of the minicells by the mammalian cells. Another drug delivery method exploits the natural ability of phagocytic mammalian cells to engulf minicells without the use of bispecific ligands.

Claim (Index 42):
The method of  claim 41 , wherein the chemotherapeutic drug is doxorubicin, vinblastine, or paclitaxel.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.77778
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14249214', '10588028', '15675548', '14506138', '15663562']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6526141212624079
- 35 USC 102 Novelty (BERT): 0.5561495629334352
- Combined Prediction Score: 0.6429676654295107
- Mean Citation Score: 424.238022
- Max Citation Score: 483.9201
- Similarity Product: 305.4973036444545

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test